Search research articles
Contact Us
Filters
Showing results (141-150 of 175) with videos related to
Page
of 18
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 9, 2018
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended Approach
Emily J Johnson, Vanessa González-Peréz, Dan-Dan Tian, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1996
First-pass metabolism of midazolam by the human intestine
M F Paine, D D Shen, K L Kunze, et al.
Clinical Pharmacology and Therapeutics
|
February 2, 2026
Pharmacokinetic Evaluation of a Cinnamon Product on CYP2A6 Substrate Drugs: Application of a Novel Tool Involving the Nicotine Metabolite Ratio
Aiden-Hung P Nguyen, Deena L Hadi, Daniel A Todd, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 28, 2014
Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction
S J Brantley, B T Gufford, R Dua, et al.
Phytotherapy Research : PTR
|
February 15, 2021
Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin-drug interactions
Katherine D Lynch, Michelle L Montonye, Dan-Dan Tian, et al.
Clinical Pharmacology and Therapeutics
|
March 16, 2023
Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom
Rakshit S Tanna, James T Nguyen, Deena L Hadi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 29, 2011
A semiphysiologically based pharmacokinetic modeling approach to predict the dose-exposure relationship of an antiparasitic prodrug/active metabolite pair
Grace Zhixia Yan, Claudia N Generaux, Miyoung Yoon, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 4, 2012
A mouse diversity panel approach reveals the potential for clinical kidney injury due to DB289 not predicted by classical rodent models
Alison H Harrill, Kristina D Desmet, Kristina K Wolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 21, 2008
The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans
Patrick J Roberts, Kristan D Rollins, Angela D M Kashuba, et al.
Bioorganic & Medicinal Chemistry
|
December 25, 2012
Enhanced bioactivity of silybin B methylation products
Arlene A Sy-Cordero, Tyler N Graf, Scott P Runyon, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 175) with videos related to
Sort By:
Page
of 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 9, 2018
Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended Approach
Emily J Johnson, Vanessa González-Peréz, Dan-Dan Tian, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1996
First-pass metabolism of midazolam by the human intestine
M F Paine, D D Shen, K L Kunze, et al.
Clinical Pharmacology and Therapeutics
|
February 2, 2026
Pharmacokinetic Evaluation of a Cinnamon Product on CYP2A6 Substrate Drugs: Application of a Novel Tool Involving the Nicotine Metabolite Ratio
Aiden-Hung P Nguyen, Deena L Hadi, Daniel A Todd, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 28, 2014
Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction
S J Brantley, B T Gufford, R Dua, et al.
Phytotherapy Research : PTR
|
February 15, 2021
Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin-drug interactions
Katherine D Lynch, Michelle L Montonye, Dan-Dan Tian, et al.
Clinical Pharmacology and Therapeutics
|
March 16, 2023
Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom
Rakshit S Tanna, James T Nguyen, Deena L Hadi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 29, 2011
A semiphysiologically based pharmacokinetic modeling approach to predict the dose-exposure relationship of an antiparasitic prodrug/active metabolite pair
Grace Zhixia Yan, Claudia N Generaux, Miyoung Yoon, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 4, 2012
A mouse diversity panel approach reveals the potential for clinical kidney injury due to DB289 not predicted by classical rodent models
Alison H Harrill, Kristina D Desmet, Kristina K Wolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 21, 2008
The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans
Patrick J Roberts, Kristan D Rollins, Angela D M Kashuba, et al.
Bioorganic & Medicinal Chemistry
|
December 25, 2012
Enhanced bioactivity of silybin B methylation products
Arlene A Sy-Cordero, Tyler N Graf, Scott P Runyon, et al.
Page
of 18